Bolt Biotherapeutics Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Stage Opera Limited OPRA Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Newmont Q1 2026 Earnings Strong EPS Beat Driven by Robust Gold Production and Cost Discipline InterDigital IDCC Q1 2026 Earnings Strong EPS Beat Overshadowed by Market Caution Concord Medical Services CCM Q2 2016 Earnings Deep EPS Miss Despite Stock Surge SDHC Q1 2026 Earnings BottomLine Beat Defies Soft Housing Headwinds